skip to main content
Idioma:
Resultados 1 2 next page
Mostrar Somente
Refinado por: assunto: Medical Sciences remover assunto: Pharmacology. Drug Treatments remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

Mateos, María-Victoria ; Hernández, José-M. ; Hernández, Miguel-T. ; Gutiérrez, Norma-C. ; Palomera, Luis ; Fuertes, Marta ; Díaz-Mediavilla, Joaquín ; Lahuerta, Juan-J. ; de la Rubia, Javier ; Terol, María-José ; Sureda, Ana ; Bargay, Joan ; Ribas, Paz ; de Arriba, Felipe ; Alegre, Adrian ; Oriol, Albert ; Carrera, Dolores ; García-Laraña, José ; García-Sanz, Ramón ; Bladé, Joan ; Prósper, Felipe ; Mateo, Gemma ; Esseltine, Dixie-Lee ; van de Velde, Helgi ; Miguel, Jesús-F. San

Blood, 2006-10, Vol.108 (7), p.2165-2172 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

Gomez-Reino, Juan J ; Maneiro, Jose Ramon ; Ruiz, Jorge ; Roselló, Rosa ; Sanmarti, Raimon ; Romero, Ana Belen

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1861-1864 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
3
Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2
Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2
Material Type:
Artigo 		Adicionar ao Meu Espaço

Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2

REAL, Pedro Jose ; YEYU CAO ; RENXIAO WANG ; NIKOLOVSKA-COLESKA, Zaneta ; SANZ-ORTIZ, Jaime ; SHAOMENG WANG ; FERNANDEZ-LUNA, Jose Luis

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (21), p.7947-7953 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
4
Clonal Spread of Levofloxacin-Resistant Streptococcus pneumoniae Invasive Isolates in Madrid, Spain, 2007 to 2009
Clonal Spread of Levofloxacin-Resistant Streptococcus pneumoniae Invasive Isolates in Madrid, Spain, 2007 to 2009
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clonal Spread of Levofloxacin-Resistant Streptococcus pneumoniae Invasive Isolates in Madrid, Spain, 2007 to 2009

RODRIGUEZ-AVIAL, Iciar ; RAMOS, Belen ; RIOS, Esther ; CERCENADO, Emilia ; ORDOBAS, Maria ; SANZ, Juan Carlos

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2469-2471 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
5
The EU-ADR Web Platform: delivering advanced pharmacovigilance tools
The EU-ADR Web Platform: delivering advanced pharmacovigilance tools
Material Type:
Artigo 		Adicionar ao Meu Espaço

The EU-ADR Web Platform: delivering advanced pharmacovigilance tools

Oliveira, José Luis ; Lopes, Pedro ; Nunes, Tiago ; Campos, David ; Boyer, Scott ; Ahlberg, Ernst ; van Mulligen, Erik M. ; Kors, Jan A. ; Singh, Bharat ; Furlong, Laura I. ; Sanz, Ferran ; Bauer-Mehren, Anna ; Carrascosa, Maria C. ; Mestres, Jordi ; Avillach, Paul ; Diallo, Gayo ; Díaz Acedo, Carlos ; van der Lei, Johan

Pharmacoepidemiology and drug safety, 2013-05, Vol.22 (5), p.459-467 [Periódico revisado por pares]

Chichester: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care
Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care
Material Type:
Artigo 		Adicionar ao Meu Espaço

Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

SOBRINO-VEGAS, Paz ; RODRIGUEZ-URREGO, Johana ; BERENGUER, Juan ; CARO-MURILLO, Ana María ; BLANCO, José Ramón ; VICIANA, Pompeyo ; MORENO, Santiago ; BERNARDINO, Ignacio ; DEL AMO, Julia ; CORIS

Antiviral therapy, 2012, Vol.17 (1), p.1-8 [Periódico revisado por pares]

London: International Medical Press

Texto completo disponível

Citações Citado por
7
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction

MARTINEZ, Esteban ; LARROUSSE, María ; PICH, Judit ; GATELL, José M ; PODZAMCZER, Daniel ; PEREZ, Ignacio ; GUTIERREZ, Félix ; LONCA, Montserrat ; BARRAGAN, Patricia ; DEULOFEU, Ramón ; CASAMITJANA, Roser ; MALLOLAS, Josep

AIDS (London), 2010-01, Vol.24 (3), p.F1-F9 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
8
Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008―2010
Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008―2010
Material Type:
Artigo 		Adicionar ao Meu Espaço

Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008―2010

JARRIN, Inma ; HERNANDEZ-NOVOA, Beatriz ; ALEJOS, Belén ; RIERA, Melchor ; NAVARRO, Gemma ; BERNARDINO, Jose Ignacio ; RIVERO, Maria ; DEL AMO, Julia ; MORENO, Santiago

Antiviral therapy, 2013-01, Vol.18 (2), p.161-170 [Periódico revisado por pares]

London: International Medical Press

Texto completo disponível

Citações Citado por
9
CD34+ Cells from Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Normal Bone Marrow Display Different Apoptosis and Drug Resistance–Associated Phenotypes
CD34+ Cells from Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Normal Bone Marrow Display Different Apoptosis and Drug Resistance–Associated Phenotypes
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD34+ Cells from Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Normal Bone Marrow Display Different Apoptosis and Drug Resistance–Associated Phenotypes

SUAREZ, Lilia ; VIDRIALES, Maria-Belén ; LAVILLA, Esperanza ; LOPEZ-BERGES, Ma Consuelo ; DE SANTIAGO, Maria ; PEREZ DE EQUIZA, M. Encarnacion ; SAN MIGUEL, Jesus F ; ORFAO, Alberto ; GARCIA-LARANA, José ; SANZ, Guillermo ; MORENO, Maria-José ; LOPEZ, Antonio ; BARRENA, Susana ; MARTINEZ, Rafael ; TORMO, Mar ; PALOMERA, Luis

Clinical cancer research, 2004-11, Vol.10 (22), p.7599-7606 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies
FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies

de la Rubia, Javier ; Regadera, Ana I. ; Martı́n, Guillermo ; Cervera, José ; Sanz, Guillermo F. ; Martı́nez, Jesús A. ; Jarque, Isidro ; Garcı́a, Inmaculada ; Andreu, Rafael ; Moscardó, Federico ; Jiménez, Carmen ; Mollá, Susana ; Benlloch, Luis ; Sanz, Miguel A.

Leukemia research, 2002-08, Vol.26 (8), p.725-730 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (18)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.